Skip to main content

Table 2 Multivariate analysis to explore risk factors for presence of DRTB, MDRTB, RRTB and INH mono-resistance

From: High prevalence of multi drug resistant tuberculosis in people living with HIV in Western India

  DRTB
OR (95% CI)
MDRTB
OR (95% CI)
RRTB
OR (95% CI)
INH mono-resistance
OR (95% CI)
Age < 30
Age 31–60 1.0 (0.2–4.3) 0.4 (0.1–4.5) 0.3 (0.1–2.9) 1.4 (0.3–6.0)
Age > 60 1.2 (0.3–4.4) 0.4 (0.1–3.9) 0.4 (0.1–3.3) 1.4 (0.4–5.1)
Gender 1.0 (0.5–2.1) 1.4 (0.5–3.6) 1.5 (0.6–3.7) 0.9 (0.4–1.9)
HIV-Duration < 5
 6–10 years 0.8 (0.3–2.3) 0.6 (0.2–2.4) 0.7 (0.3–2.3) 0.8 (0.2–2.4)
  > 10 years 1.6 (0.5–4.7) 1.1(0.3–5.1) 1.3 (0.5–4.7) 1.5 (0.3–4.9)
CD4 counts < 50
 51–100 0.6 (0.2–1.8) 0.2 (0.1–1.2) 0.3 (0.1–1.2) 0.6 (0.2–1.8)
  > 100 0.7 (0.3–1.6) 0.5 (0.1–1.2) 0.5 (0.1–1.5) 0.7 (0.3–1.7)
ART status 1.0 (0.5–2.4) 1.1 (0.4–3.2) 1.2 (0.5–3.1) 1.0 (0.4–2.4)
Type of TB: EPTB 0.6 (0.3–1.3) 0.5 (0.1–1.2) 0.6 (0.2–1.4) 0.6 (0.3–1.2)
Primary and relapse 2.4 (1.2–4.9)* 2.5 (1.0–6.3)** 2.18 (1.0–5.1) 2.6 (1.2–5.5)***
  1. *p = 0.018, **p = 0.048, *** p = 0.012
  2. The outcome variable was treated as dichotomous variable (MDRTB vs non-MDRTB, DRTB vs non-DRTB, RRTB vs non-RRTB and INH mono-resistant TB vs non-INH mono-resistant TB)
  3. Odds Ratio (OR)
\